Liu et al. BMC Public Health 2011, 11:931 http://www.biomedcentral.com/1471-2458/11/931 13. Martiniuk AL, Lee CM, Lawes CM, Ueshima H, Suh I, Lam TH, Gu D, Feigin V, Jamrozik K, Ohkubo T, et al: Hypertension: its prevalence and population- attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens 2007, 25:73-79. 14. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J: Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004, 22:11-19. 15. Addo J, Smeeth L, Leon DA: Hypertension in sub-saharan Africa: a systematic review. Hypertension 2007, 50:1012-1018. 16. Tao SC, Huang ZD, Wu XG, Zhou BF, Xiao ZK, Hao JS, Li YH, Cen RC, Rao XX: CHD and its risk factors in the People’s Republic of China. Int J Epidemiol 1989, 18(3 Suppl 1):S159-S163. 17. People’s Republic of China–United States Cardiovascular and Cardiopulmonary Epidemiology Research Group: An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People’s Republic of China. Baseline report from the P.R.C.-U.S.A. Collaborative Study. Circulation 1992, 85:1083-1096. 18. Liang KY, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22. 19. Tunstall-Pedoe H, Connaghan J, Woodward M, Tolonen H, Kuulasmaa K: Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication. BMJ 2006, 332:629-635. 20. Capewell S, Ford ES, Croft JB, Critchley JA, Greenlund KJ, Labarthe DR: Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bull World Health Organ 2010, 88:120-130. 21. Jacobs DR Jr, Hannan PJ, Wallace D, Liu K, Williams OD, Lewis CE: Interpreting age, period and cohort effects in plasma lipids and serum insulin using repeated measures regression analysis: the CARDIA Study. Stat Med 1999, 18:655-679. 22. Ma WJ, Xu YJ, Li JS, Xu HF, Nie SP, Chen ZC, Deng HH, Li HK: Epidemiological study of overweight and obesity in Guangdong Province, 2002 (in Chinese). Chin J Epidemiol 2004, 25:1035-1038. 23. Zhai F, Wang H, Du S, He Y, Wang Z, Ge K, Popkin BM: Prospective study on nutrition transition in China. Nutr Rev 2009, 67(Suppl 1):S56-S61. 24. Liu XQ, Li YH: Epidemiological and nutritional research on prevention of cardiovascular disease in China. Br J Nutr 2000, 84(Suppl 2):S199-S203. 25. Anderson JT, Jacobs DR Jr, Foster N, Hall Y, Moss D, Mojonnier L, Blackburn H: Scoring systems for evaluating dietary pattern effect on serum cholesterol. Prev Med 1979, 8:525-537. 26. Hook W, Ernst J: Bicycle use plunges: The struggle for sustainability in China’s cities. Sustainable Transport 10, New York: Institute for Transportation and Development Policy; 1999, 18-19. 27. Georges Darido, Mariana Torres-Montoya, Shomik Mehndiratta: Urban transport and CO2 emissions: some evidence from Chinese cities. The World Bank Report 2009, 55773. 28. Hu TW, Mao Z, Ong M, Tong E, Tao M, Jiang H, Hammond K, Smith KR, de Beyer J, Yurekli A: China at the crossroads: the economics of tobacco and health. Tob Control 2006, 15(Suppl 1):i37-i41. 29. Liu J, Hong Y, D’Agostino RB Sr, Wu Z, Wang W, Sun J, Wilson PW, Kannel WB, Zhao D: Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 2004, 291:2591-2599. 30. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913. 31. Rodgers A, Lawes C, MacMahon S: Reducing the global burden of blood pressure-related cardiovascular disease. J Hypertens Suppl 2000, 18:S3-6. 32. Eastern Stroke and Coronary Heart Disease Collaborative Research Group: Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 1998, 352:1801-1807. 33. Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W: Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ 1991, 303:276-282. 34. Nolte E, Shkolnikov V, McKee M: Changing mortality patterns in East and West Germany and Poland. II: short-term trends during transition and in the 1990s. J Epidemiol Community Health 2000, 54:899-906. 35. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R: Body-mass index and cause-specific Page 9 of 9 mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009, 373:1083-1096. 36. Causation and causal inference. Edited by: Rothman KJ, Greenland S, Poole C, Lash TL. Philadelphia, PA: Lippincott Williams , 3 2008. 37. Strasser T: Reflections on cardiovascular diseases. Interdisc Sci Rev 1978, 3:225-230. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2458/11/931/prepub doi:10.1186/1471-2458-11-931 Cite this article as: Liu et al.: Adverse trends of cardiovascular risk factors among low risk populations (1983-1994) - a cohort study of workers and farmers in Guangzhou, China. BMC Public Health 2011 11:931. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit